To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Dr. Cackowski earned his M.D. and Ph.D. degrees from the University of Pittsburgh and then completed his Internal Medicine Residency and subsequently, his Hematology/Oncology Fellowship at the University of Michigan in 2017.
While at the University of Michigan as a fellow and later as a Clinical Lecturer, he developed particular expertise in the treatment of patients with genitourinary cancers. He also developed a laboratory research program studying prostate cancer dormancy and recurrence — how patients with prostate cancer can relapse months, years, or decades after curative-intent surgery or radiation. His research laboratory is funded by grants from the Prostate Cancer Foundation and the Department of Defense.
Dr. Cackowski joined the medical staff at Karmanos Cancer Center and Wayne State University in May 2020 where he continues to treat patients with genitourinary cancers, leads a laboratory investigating ways in which prostate cancer recurs and resists treatment and conducts clinical trials of genitourinary cancers.
Elisabeth Heath, M.D., FACP , leader of the Genitourinary Oncology Multidisciplinary Team (MDT) and member of the Phase 1 Clinical Trials MDT at the Barbara Ann Karmanos Cancer Institute, has received grant renewal from the U.S. Department of Defense to continue membership in the prestigious Prostate Cancer Clinical Trials Consortium (PCCTC) program. The Prostate Cancer Clinical Consortium Award is a peer-reviewed, competitive grant. Peers include scientific researchers at universities and cancer center...